4//SEC Filing
SANDS ARTHUR T 4
Accession 0001209191-23-009710
CIK 0001549595other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:12 PM ET
Size
9.3 KB
Accession
0001209191-23-009710
Insider Transaction Report
Form 4
SANDS ARTHUR T
DirectorPresident, CEO
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-14+448,000→ 448,000 totalExercise: $10.83Exp: 2033-02-13→ Common Stock (448,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/36 of the total shares monthly beginning March 14, 2023 until the option is fully vested on February 14, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001134106
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:12 PM ET
- Size
- 9.3 KB